Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Alcidion has completed a fundraising
Healthcare

Alcidion has completed a fundraising

Alcidion Group Ltd. (ASX:ALC) has raised funds to acquire Silverlink PCS Software Limited.

Learn more
Alcidion acquires Silverlink Software
Healthcare

Alcidion acquires Silverlink Software

Alcidion Group Ltd. (ASX:ALC) has acquired Silverlink PCS Software Limited.

Learn more
Converge International receives investment from the Victorian Business Growth Fund
Private Equity | Healthcare

Converge International receives investment from the Victorian Business Growth Fund

Converge International has raised funds from the Victorian Business Growth Fund. The investment was managed by ROC Partners and the capital raised will be used to fund the acquisition of HeadUp Labs and support future growth.

Learn more
“From the commencement of the engagement with Oaklins, we were delighted by the speed with which they were able to grasp Converge’s vision and strategy, understand and provide advice on the ‘buy’ vs ‘build’ options and identify highly synergistic value-adding acquisition opportunities, the best sources of capital, and act on behalf of Converge to progressively finetune the approach and support the buy-side and investor negotiations. At all times, the team provided Converge with advice that was proactive, wise and transparent. It has been a genuine partnership which we look forward to continuing with them as we seek further M&A opportunities to support our growth.”

Terry Winters

Chairman, Converge International

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AU&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Belgian radioisotope producer secures US$104.1 million to expand global production

DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Learn more

Talk to our local advisors

Peter Fraser

Director
Sydney, Australia
Oaklins Henslow

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital